Role of aromatic side chains in amyloid β-protein aggregation

ACS Chemical Neuroscience

Volumn 3, Issue 12, 2012, Pages 1008-1016

  Cukalevski, Risto ^a   Boland, Barry ^b   Frohm, Birgitta ^a   Thulin, Eva ^a   Walsh, Dominic ^b,c   Linse, Sara ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

aggregation, kinetics; Alzheimer's; Amyloid; phenylalanine; stacking

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AROMATIC COMPOUND; LEUCINE; MONOMER; PHENYLALANINE; THIOFLAVINE;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; FIBER; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE; REPRODUCIBILITY; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CIRCULAR DICHROISM; KINETICS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY;

EID: 84871285635     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300073s     Document Type: Article

References (50)

1. Selkoe, D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399, A23-31
2. Hardy, J. and Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends Pharmacol. Sci. 12, 383-388
3. Selkoe, D. J. (1991) The molecular pathology of Alzheimer's disease Neuron 6, 487-498
4. Golde, T. E., Schneider, L. S., and Koo, E. H. (2011) Anti-abeta therapeutics in Alzheimer's disease: the need for a paradigm shift Neuron 69, 203-213
5. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297, 353-356 (Pubitemid 34790756)
6. Qiu, W. Q. and Folstein, M. F. (2006) Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis Neurobiol. Aging 27, 190-198 (Pubitemid 43038542)
7. Selkoe, D. J. (2000) The origins of Alzheimer disease: a is for amyloid JAMA. J. Am. Med. Assoc. 283, 1615-1617 (Pubitemid 30161520)
8. De Strooper, B. (2010) Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process Physiol. Rev. 90, 465-494
9. Walsh, D. M. and Selkoe, D. J. (2007) A beta oligomers-a decade of discovery J. Neurochem. 101, 1172-1184
10. Lacor, P. N., Buniel, M. C., Furlow, P. W., Clemente, A. S., Velasco, P. T., Wood, M., Viola, K. L., and Klein, W. L. (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease J. Neurosci. 27, 796-807 (Pubitemid 46174498)
11. Hung, L. W., Ciccotosto, G. D., Giannakis, E., Tew, D. J., Perez, K., Masters, C. L., Cappai, R., Wade, J. D., and Barnham, K. J. (2008) Amyloid-beta peptide (Aβ neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity J. Neurosci. 28, 11950-11958
12. Walsh, D. M. and Selkoe, D. J. (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease Neuron 44, 181-193 (Pubitemid 39348839)
13. Roher, A. E., Chaney, M. O., Kuo, Y. M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., Bonnell, B. S., and Emmerling, M. R. (1996) Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease J. Biol. Chem. 271, 20631-20635 (Pubitemid 26281842)
14. Jan, A., Adolfsson, O., Allaman, I., Buccarello, A. L., Magistretti, P. J., Pfeifer, A., Muhs, A., and Lashuel, H. A. (2011) Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species J. Biol. Chem. 286, 8585-8596
15. Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., and Rydel, R. E. (2005) Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death J. Neurosci. 25, 1071-1080 (Pubitemid 41741352)
16. Esler, W. P., Stimson, E. R., Ghilardi, J. R., Lu, Y. A., Felix, A. M., Vinters, H. V., Mantyh, P. W., Lee, J. P., and Maggio, J. E. (1996) Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence Biochemistry 35, 13914-13921 (Pubitemid 26374462)
17. Tjernberg, L. O., Callaway, D. J., Tjernberg, A., Hahne, S., Lilliehook, C., Terenius, L., Thyberg, J., and Nordstedt, C. (1999) A molecular model of Alzheimer amyloid beta-peptide fibril formation J. Biol. Chem. 274, 12619-12625
18. Hilbich, C., Kisterswoike, B., Reed, J., Masters, C. L., and Beyreuther, K. (1992) Substitutions of hydrophobic amino-acids reduce the amyloidogenicity of Alzheimers-disease beta-A4 peptides J. Mol. Biol. 228, 460-473 (Pubitemid 23007569)
19. de Groot, N. S., Aviles, F. X., Vendrell, J., and Ventura, S. (2006) Mutagenesis of the central hydrophobic cluster in A beta 42 Alzheimer's pepticle-Side-chain properties correlate with aggregation propensities FEBS J. 273, 658-668
20. Gazit, E. (2002) A possible role for pi-stacking in the self-assembly of amyloid fibrils FASEB J. 16, 77-83 (Pubitemid 34027953)
21. Chalifour, R. J., McLaughlin, R. W., Lavoie, L., Morissette, C., Tremblay, N., Boule, M., Sarazin, P., Stea, D., Lacombe, D., Tremblay, P., and Gervais, F. (2003) Stereoselective interactions of peptide inhibitors with the beta-amyloid peptide J. Biol. Chem. 278, 34874-34881 (Pubitemid 37102246)
22. Gordon, D. J., Sciarretta, K. L., and Meredith, S. C. (2001) Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues Biochemistry 40, 8237-8245 (Pubitemid 32661883)
23. Porat, Y., Abramowitz, A., and Gazit, E. (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism Chem. Biol. Drug Des. 67, 27-37 (Pubitemid 43881385)
24. Rauk, A. (2009) The chemistry of Alzheimer's disease Chem. Soc. Rev. 38, 2698-2715
25. Scherzer-Attali, R., Pellarin, R., Convertino, M., Frydman-Marom, A., Egoz-Matia, N., Peled, S., Levy-Sakin, M., Shalev, D. E., Caflisch, A., Gazit, E., and Segal, D. (2010) Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor PLoS One 5, e11101
26. Soto, C., Sigurdsson, E. M., Morelli, L., Kumar, R. A., Castano, E. M., and Frangione, B. (1998) Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy Nat. Med. 4, 822-826 (Pubitemid 28331024)
27. Tjernberg, L. O., Naslund, J., Lindqvist, F., Johansson, J., Karlstrom, A. R., Thyberg, J., Terenius, L., and Nordstedt, C. (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand J. Biol. Chem. 271, 8545-8548 (Pubitemid 26123269)
28. Wood, S. J., Wetzel, R., Martin, J. D., and Hurle, M. R. (1995) Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4 Biochemistry 34, 724-730
29. Minor, D. L., Jr. and Kim, P. S. (1994) Context is a major determinant of beta-sheet propensity Nature 371, 264-267 (Pubitemid 24293028)
30. Armstrong, A. H., Chen, J., McKoy, A. F., and Hecht, M. H. (2011) Mutations that replace aromatic side chains promote aggregation of the Alzheimer's Abeta peptide Biochemistry 50, 4058-4067
31. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate J. Biol. Chem. 272, 22364-22372 (Pubitemid 27382873)
32. Cannon, M. J., Williams, A. D., Wetzel, R., and Myszka, D. G. (2004) Kinetic analysis of beta-amyloid fibril elongation Anal. Biochem. 328, 67-75 (Pubitemid 38479619)
33. Bertini, I., Gonnelli, L., Luchinat, C., Mao, J., and Nesi, A. (2011) A new structural model of Abeta40 fibrils J. Am. Chem. Soc. 133, 16013-16022
34. Paravastu, A. K., Leapman, R. D., Yau, W. M., and Tycko, R. (2008) Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils Proc. Natl. Acad. Sci. U.S.A. 105, 18349-18354
35. Petkova, A. T., Yau, W. M., and Tycko, R. (2006) Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils Biochemistry 45, 498-512 (Pubitemid 43100415)
36. Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., and Smith, S. O. (2010) Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils Nat. Struct. Mol. Biol. 17, 561-567
37. Inouye, H., Gleason, K. A., Zhang, D., Decatur, S. M., and Kirschner, D. A. (2010) Differential effects of Phe19 and Phe20 on fibril formation by amyloidogenic peptide A beta 16-22 (Ac-KLVFFAE-NH2) Proteins 78, 2306-2321
38. Creighton, T. E. (1993) Proteins: structures and molecular properties, 2 nd ed., pp 4 and 256, W. H. Freeman, New York.
39. Wolfenden, R. (2007) Experimental measures of amino acid hydrophobicity and the topology of transmembrane and globular proteins J. Gen. Physiol. 129, 357-362 (Pubitemid 46686451)
40. Hellstrand, E., Boland, B., Walsh, D. M., and Linse, S. (2010) Amyloid beta-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process ACS Chem. Neurosci. 1, 13-18
41. Naiki, H., Higuchi, K., Hosokawa, M., and Takeda, T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1 Anal. Biochem. 177, 244-249 (Pubitemid 19088253)
42. Levine, H. (1995) Thioflavine-T Interaction with Amyloid β-Sheet Structures Amyloid 2, 1-6
43. Cohen, S. I., Linse, S., Luheshi, L., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. J. (2012) Unpublished experiment.
44. Cohen, S. I., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. (2012) From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation J. Mol. Biol. 421, 160-171
45. Biancalana, M. and Koide, S. (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils Biochim. Biophys. Acta 1804, 1405-1412
46. Tew, D. J., Bottomley, S. P., Smith, D. P., Ciccotosto, G. D., Babon, J., Hinds, M. G., Masters, C. L., Cappai, R., and Barnham, K. J. (2008) Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide Biophys. J. 94, 2752-2766
47. Maji, S. K., Loo, R. R. O., Inayathullah, M., Spring, S. M., Vollers, S. S., Condron, M. M., Bitan, G., Loo, J. A., and Teplow, D. B. (2009) Amino Acid Position-specific Contributions to Amyloid beta-Protein Oligomerization J. Biol. Chem. 284, 23580-23591
48. Adachi, R., Yamaguchi, K., Yagi, H., Sakurai, K., Naiki, H., and Goto, Y. (2007) Flow-induced alignment of amyloid protofilaments revealed by linear dichroism J. Biol. Chem. 282, 8978-8983 (Pubitemid 47093478)
49. Kim, W. and Hecht, M. H. (2006) Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's A beta 42 peptide Proc. Natl. Acad. Sci. U.S.A. 103, 15824-15829 (Pubitemid 44657551)
50. Walsh, D. M., Thulin, E., Minogue, A. M., Gustavsson, N., Pang, E., Teplow, D. B., and Linse, S. (2009) A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide FEBS J. 276, 1266-1281